Work With Data
search
live In the news:
Pharmac escapes US plea for Donald Trump to tariff Australia over drug prices / Endometriosis: Tauranga woman welcomes Pharmac's decision to fund Cerazette / Pharmac report shows 'gulf' between leadership and patients, says management lacks respect, too defensive / Sarah Fitt resigns as Pharmac chief executive / Pharmac funds new cancer, RSV, COPD treatments / Pharmac to disestablish its Maori advisory group / Pharmac to fund new ADHD medicine / Pharmac proposes to fund new blood cancer multiple myeloma drug pomalidomide / Health explainer: Pharmac's funding of glucose monitors a major step - with a few catches / Pharmac leaves blanket funding for treatment of children with cancer

U.S. Pharmacist

Updated: 66d ago

U.S. Pharmacist is a company. It is a private company in the United States.

Key facts

  • country: United States
  • employees: 901 people
  • revenues: 35.6M $
  • company type: private
  • ESG score: 78.41 / 100
plus See more facts
link Website
link X (Twitter): 7K followers

Extract data

Download datasets about U.S. Pharmacist:

dataset Dataset of stocks from U.S. Pharmacist:

U.S. Pharmacist is one of the companies in the United States and 3,456,808 companies in our database.

Talking Points

  • U.S. Pharmacist – The Leading Journal in Pharmacy
  • U.S. Pharmacist is the leading clinically-focused monthly pharmacy publication providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice.
  • U.S. Pharmacist is a clinical resource for pharmacists - dedicated to providing up-to-date, authoritative, peer-reviewed articles in print, online and emails.

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter.

This content is available under the CC BY 4.0 license.